Clinical Trial Update: Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) [Phase 4]

View source ↗

Summary

Phase 4 trial update reports on quality of life improvements for asthma and allergic rhinitis patients treated with montelukast (Singulair).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma, Rhinitis Allergic | Phase 4 | Status: COMPLETED